Categories: Wire Stories

AHF Praises Merck for Generics � Urges Same from Vaccine Makers

LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) today applauded Merck and the Medicines Patent Pool (MPP) for their recent sublicensing agreements with 27 generic drug companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir, giving 105 low- and-middle-income countries (LMICs) access to the drug. AHF also urged Pfizer, Moderna, and Johnson & Johnson to follow suit by sharing their COVID-19 vaccine know-how and technology that would allow LMICs to produce generic, lifesaving doses locally.

�We praised Merck last October for its voluntary licensing agreement with MPP. Their efforts are now coming to fruition with an affordable generic anti-COVID treatment that will be available in more than 100 lower-income countries,” said Dr. Jorge Saavedra, Executive Director of the AHF Institute for Global Public Health at the University of Miami. “Now, if some of this common sense and goodwill displayed by Merck would rub off on the big three vaccine makers, the world can begin to end the pandemic with sufficient vaccine access in all countries – not just those with wealth.”

India and South Africa led a World Trade Organization proposal to waive intellectual property protections on COVID-19 vaccines in December 2020 that more than 120 countries also supported. So far, even with an immoral and glaring discrepancy in global vaccine access between rich and poorer countries, neither Pfizer, Moderna, or J&J have budged on granting access to their vaccine recipes or technologies.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million clients in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

US MEDIA CONTACT:

Ged Kenslea, Senior Director, Communications, AHF

+1.323.308.1833 work

+1.323.791.5526 mobile

gedk@aidshealth.org

Denys Nazarov, Director of Global Policy &

Communications, AHF

+1 323.308.1829

denys.nazarov@ahf.org

Alex

Recent Posts

China Focus: Technology sows seeds of hope in combating desertification

HOHHOT, CHINA - Media OutReach Newswire - 23 December 2024 - China's National Forestry and…

10 hours ago

Novautek Honored with the “Outstanding SME ESG and Business Performance Award”

HONG KONG SAR - EQS Newswire - 23 December 2024 - Novautek Autonomous Driving Limited…

12 hours ago

V-GREEN and Xanh SM Indonesia sign MoU with Lippo for comprehensive green ecosystem in Indonesia

JAKARTA, INDONESIA - Media OutReach Newswire - 23 December 2024 - V-GREEN and PT Xanh…

12 hours ago

Molex Anticipates Steady Growth in High-Speed Connectivity in 2025, Driving Electronics Design Innovations Across Diverse Industry Sectors

Increase in opportunities predicted for high-speed optical transceivers and miniaturized connectivity solutions to address data-intensive…

14 hours ago

Celebrating 25 Years of Excellence: DYXnet Embarks the New Chapter of Digital Transformation

HONG KONG SAR - Media OutReach Newswire - 23 December 2024 - DYXnet, a wholly-owned…

15 hours ago

The Top 10 Best Places to Work in Egypt for 2024 revealed

CAIRO, EGYPT - Media OutReach Newswire - 23 December 2024 - Eand, Novo Nordisk, BSH,…

17 hours ago